Results: 6

X-linked hypophosphatemic rickets: a new mutation

J. bras. nefrol; 43 (2), 2021
Abstract Phosphopenic rickets may be caused by mutations in the PHEX gene (phosphate regulating endopeptidase homolog X-linked). Presently, more than 500 mutations in the PHEX gene have been found to cause hypophosphatemic rickets. The authors report a clinical case of a 4-year-old girl with unremarkable...

Metabolic assessment in pure struvite stones formers: is it necessary?

J. bras. nefrol; 43 (2), 2021
Abstract Background and objective: Magnesium ammonium phosphate stones (MAP), also known as struvite stones, are associated with urinary infection and impairment of renal unit. The aim of this study is to evaluate the urinary metabolic risk factors for recurrence of renal calculi in patients submitted ...

Prevalence and clinical characteristics of X-linked hypophosphatemia in Paraná, southern Brazil

ABSTRACT Objective: The aim of this cross-sectional study was to estimate the prevalence of XLH in Paraná, a state in southern Brazil, and report the clinical features and complications of the disease. Materials and methods: We invited all endocrinologists (n = 205), nephrologists (n = 221), orthopedi...

Medium modification with bone morphogenetic protein 2 addition for odontogenic differentiation

Braz. oral res. (Online); 30 (1), 2016
Abstract The aim of this study was to evaluate whether medium modification improves the odontogenic differentiation of human dental pulp stem cells (DPSC) in vitro and in vivo. DPSC isolated from human impacted third molar teeth were analysed for clusters of differentiation with flow cytometry. Odontogen...

In vivo performance of different scaffolds for dental pulp stem cells induced for odontogenic differentiation

Braz. oral res. (Online); 30 (1), 2016
Abstract This study was designed to determine the in vivo performance of three different materials as scaffolds for dental pulp stem cells (DPSC) undergoing induced odontogenic differentiation. An odontogenic medium modified by the addition of recombinant human bone morphogenetic protein 2 was used in th...

Anticuerpos ANTI-FGF23 en el tratamiento del raquitismo hipofosfatémico ligado al X: luces y sombras
ANTI-FGF23 antibodies in the treatment of X-linked hypophosphatemic rickets: lights and shadows

Actual. osteol; 12 (3), 2016